Case opinion for US Supreme Court BRUESEWITZ ET AL. v. ... It granted Wyeth summary judgment, holding that the relevant Pennsylvania law was preempted ...
Bruesewitz v. Wyeth's Impact on the Vaccine Safety Debate. By Erin C. Fuse Brown1 & Jalayne J. Arias2, Public Health Law and Policy Program at Sandra Day ...
Oct 12, 2010 ... Bruesewitz v. ... Wyeth, Inc., fka Wyeth Laboratories, et al. ... The Bruesewitzes filed a lawsuit against Wyeth in state court in Pennsylvania.
Dec 22, 2015 ... To resolve this apparent inconsistency, Wang et al. ... xylazine (10 mg/kg i.p.; Bayer Inc., Canada) and ketamine (50 mg/kg i.p.; Wyeth, Canada).
Aug 1, 2010 ... Aleksandra Bortel,a Maxime Lévesque,a Giuseppe Biagini,b Jean ... However, little effort (but see Biagini et al., 2006; Klitgaard et al., ... ketamine (50 mg/kg, i.p.; Wyeth, Canada) (Martin and Kapur, 2008). .... **p<0.01 between latent period versus chronic period; LSD test after significant two-way ANOVA.
Mar 22, 2011 ... Claude-Édouard Châtillon,a,* Rina Zelmann,b Aleksandra Bortel,b .... A comparison of HFO duration versus contact size was also performed. Go to: 2. Methods. The intraperitoneal pilocarpine rat model was used (Turski et al., 1983). ... and ketamine (50 mg/kg IP: Wyeth, Canada), injected separately.
Mar 15, 2016 ... All filorexant doses (2.5/5/10/20mg) were significantly superior to placebo in ... for 4 weeks (Herring et al., 2012), almorexant (singe-dose) (Hoever et al., 2012), .... with 95% CIs provided for comparisons of treatment vs placebo. ...... Syrex, Takeda, TransOral, Wyeth, and Xenoport; has acted as a consultant ...
Apr 21, 2011 ... The study by D'Anglejan-Chatillon et al. enrolled 25 men and 25 women with extracranial ..... McNeil Consumer & Specialty Pharmaceuticals, Merck, and Wyeth Consumer Healthcare; ... Vanmolkot FH, Van Bortel LM, de Hoon JN. ... Metso TM, Metso AJ, Salonen O, Haapaniemi E, Putaala J, Artto V, et al.
Sep 23, 2010 ... described in detail in recent reviews (Esbenshade et al., 2008; Leurs ... agonism versus antagonism in the in vivo situation, thus, for the ..... including Schering ( SCH-497079), Servier (S-41150), Arena (APD916), Wyeth/Pfizer ..... Calder N, Marsilio S, Cerchio K, Declercq R, Fox-Bosetti S, Verma A, Bortel Lv, ...